Ceramide: A common pathway for atherosclerosis?
- 29 February 2008
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 196 (2), 497-504
- https://doi.org/10.1016/j.atherosclerosis.2007.09.018
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory propertyMedical Hypotheses, 2007
- Vasculoprotective Effects of Anti-Tumor Necrosis Factor-α Treatment in AgingThe American Journal of Pathology, 2007
- Sphingomyelinase causes endothelium‐dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca2+ elevationFEBS Letters, 2004
- Role for Matrix Metalloproteinase-2 in Oxidized Low-Density Lipoprotein–Induced Activation of the Sphingomyelin/Ceramide Pathway and Smooth Muscle Cell ProliferationCirculation, 2004
- Identification of the LIM kinase-1 as a ceramide-regulated gene in renal mesangial cellsBiochemical and Biophysical Research Communications, 2002
- Extracellular proteolysis in the development and progression of atherosclerosisBiochemical Society Transactions, 2002
- Effects of Tumor Necrosis Factor-α on Basal and Stimulated Endothelium-Dependent Vasomotion in Human Resistance VesselJournal of Cardiovascular Pharmacology, 2000
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH: IMPLICATIONS FOR ATHEROSCLEROTIC LESION DEVELOPMENTJournal of Biological Chemistry, 1998
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Activities of the initial enzymes of glycerolipid and sphingolipid synthesis in lung microsomes from rats exposed to air or 85% oxygenBiochemical and Biophysical Research Communications, 1984